16-01-2014
Going over recent EFSA opinions on health claim applications it is amazing to notice that still companies do not fully realize what it takes ‘to tango’ a health claim. What a waste of time and money! Should you already have prepared a dossier, run an independent pre-submission check (see my previous post). But even when only study reports and data are […]
>> read more
Presubmission dossier check!
15-02-2013
The continuing series of health claims rejections is really raising the question of what’s going on here. Is EFSA really impossible, as has been suggested more than once? Is nutrition science all that impossible to come to terms with when it comes to providing convincing evidence for a physiological effect?. Or do we still have to get rid of a mind-set […] >> read more
The continuing series of health claims rejections is really raising the question of what’s going on here. Is EFSA really impossible, as has been suggested more than once? Is nutrition science all that impossible to come to terms with when it comes to providing convincing evidence for a physiological effect?. Or do we still have to get rid of a mind-set […] >> read more
NutriClaim authored Datamonitor’s Health Claims 2012 report.
16-01-2013
This report considers the implications of the adoption of EC Regulation 1924/2006. In addition to summarizing the results of the new legislation, the report examines what options now face manufacturers in this sector, what strategies can be employed to navigate the new regulations, and what opportunities have emerged due to the changing regulatory environment. For many ingredients left without a […] >> read more
This report considers the implications of the adoption of EC Regulation 1924/2006. In addition to summarizing the results of the new legislation, the report examines what options now face manufacturers in this sector, what strategies can be employed to navigate the new regulations, and what opportunities have emerged due to the changing regulatory environment. For many ingredients left without a […] >> read more
The thorny issue of using questionnaires in health claim-targeted RCTs.
02-11-2012
Questionnaires are often used in clinical and nutritional research to subjectively evaluate the effect of an intervention on an outcome measure or e.g. to select a study population with specific characteristics from a larger pool of potential study participants. Nevertheless, their thoughtless application in health claim-targeted studies have frequently resulted in EFSA dismissing the outcomes generated by these questionnaires. Validation […] >> read more
Questionnaires are often used in clinical and nutritional research to subjectively evaluate the effect of an intervention on an outcome measure or e.g. to select a study population with specific characteristics from a larger pool of potential study participants. Nevertheless, their thoughtless application in health claim-targeted studies have frequently resulted in EFSA dismissing the outcomes generated by these questionnaires. Validation […] >> read more
Chocolate? Beyond confectionary!
29-10-2012
What makes cocoa antioxidants so attractive? Are cocoa flavanols rivalling the success of superfruit as health powerhouses? Updates on recently applied cocoa health claims under the European Union nutrition and health claims regulations. Take your sweets! Fi-Conference 2012 – Natural Antioxidants Module 4B >> read more
What makes cocoa antioxidants so attractive? Are cocoa flavanols rivalling the success of superfruit as health powerhouses? Updates on recently applied cocoa health claims under the European Union nutrition and health claims regulations. Take your sweets! Fi-Conference 2012 – Natural Antioxidants Module 4B >> read more
Health Claims Consultant Dr. Stoffer Loman of NutriClaim speaks at FI Europe 2012
29-10-2012
How to capitalize on existing research to push your health claim through? Health claims for Cardiovascular health benefits were among the first to be authorized. Even, up to now the majority of authorized health claims relate to cardiovascular health. However, despite a wealth of existing scientific research, soy proteins did not achieve ‘health claim’ status. Is the effect just not […] >> read more
How to capitalize on existing research to push your health claim through? Health claims for Cardiovascular health benefits were among the first to be authorized. Even, up to now the majority of authorized health claims relate to cardiovascular health. However, despite a wealth of existing scientific research, soy proteins did not achieve ‘health claim’ status. Is the effect just not […] >> read more
Claimed effect – Chocolate milk refuels muscles after exercise!
04-05-2012
Will this Sports Nutrition Claim drive chocolate milk into the fast lane? Recent studies have indeed shown that chocolate milk aids recovery from intense physical exercise as good as any sports recov drink. Due to its naturally balanced composition, glycogen stores are replenished and protein synthesis is stimulated. At least, that is what the studies tell us. Will EFSA judge the same? […] >> read more
Will this Sports Nutrition Claim drive chocolate milk into the fast lane? Recent studies have indeed shown that chocolate milk aids recovery from intense physical exercise as good as any sports recov drink. Due to its naturally balanced composition, glycogen stores are replenished and protein synthesis is stimulated. At least, that is what the studies tell us. Will EFSA judge the same? […] >> read more
NutriClaim invited speaker 4th Fresenius International Conference Health Claims
07-03-2012
NutriClaim’s presentation will deal with the issue of to what extent ‘established’ scientific concepts are really fit for health claims substantiation. In addition to EFSA’s scientific guidance documents, guidance provided by opinions will be discussed. Examples will be taken from opinions on probiotics and immunity, walnuts and endothelium-dependent vasodilation, carotenoids and photoprotection and soy protein and cholesterol. Implications for […] >> read more
NutriClaim’s presentation will deal with the issue of to what extent ‘established’ scientific concepts are really fit for health claims substantiation. In addition to EFSA’s scientific guidance documents, guidance provided by opinions will be discussed. Examples will be taken from opinions on probiotics and immunity, walnuts and endothelium-dependent vasodilation, carotenoids and photoprotection and soy protein and cholesterol. Implications for […] >> read more
NutriClaim to present on Probiotic Claims at Health Claim Conference
23-10-2011
During the upcoming 7th International Workshop Nutrition & Health Claims Europe, NutriClaim will shed its light on why, up till now, all health claim submissions for probiotics have received a negative opinion from EFSA. The presentation will focus on art. 13.5 and 14 health claims evaluations, primarily pertaining to gastrointestinal and immune health benefits of probiotics. For the full program: […] >> read more
During the upcoming 7th International Workshop Nutrition & Health Claims Europe, NutriClaim will shed its light on why, up till now, all health claim submissions for probiotics have received a negative opinion from EFSA. The presentation will focus on art. 13.5 and 14 health claims evaluations, primarily pertaining to gastrointestinal and immune health benefits of probiotics. For the full program: […] >> read more
Will EFSA accept that Bifidobacterium BB-12 really improves immune function?
07-10-2011
Recently, Rizzardini et al. (B. J. Nutr. 2011) showed that in a vaccination model in healthy subjects supplementation with either Bifidobacterium BB-12 or Lactobacillus casei 431 resulted in significantly greater mean fold increases in total and vaccine-specific antibody titers. However, the question remains whether the observed and statistically significant differences will also be perceived as physiologically relevant by EFSA in […] >> read more
Recently, Rizzardini et al. (B. J. Nutr. 2011) showed that in a vaccination model in healthy subjects supplementation with either Bifidobacterium BB-12 or Lactobacillus casei 431 resulted in significantly greater mean fold increases in total and vaccine-specific antibody titers. However, the question remains whether the observed and statistically significant differences will also be perceived as physiologically relevant by EFSA in […] >> read more